Vistagen To Report Second Quarter Financial Results and Host Corporate Update Conference Call on November 9, 2023

Rhea-AI Summary

Vistagen (NASDAQ: VTGN) will host a conference call and webcast on November 9, 2023, to provide a corporate update and report results for its fiscal year 2024 second quarter. The event will start at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). Participants can access the webcast via the provided link and a telephone playback will be available after the call.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system (CNS) disorders, today announced it will host a conference call and webcast on Thursday, November 9, 2023, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to provide a corporate update and report results for its fiscal year 2024 second quarter ended September 30, 2023.

Event: Vistagen Fiscal Year 2024 Second Quarter Corporate Update Conference Call
Date: Thursday, November 9, 2023
Time: 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time)
US Dial-in (Toll-free): 1-800-245-3047
TOLL/International Dial-in: 1-203-518-9765
Conference ID: 11153994
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1641124&tp_key=2213157260

An audio webcast of the conference call will also be available via the link provided above. Participants should access this webcast site 10 minutes before the start of the call. In addition, a telephone playback of the call will be available after approximately 5:00 p.m. Pacific Time (8:00 p.m. Eastern Time) on Thursday, November 9, 2023. To listen to the replay, call toll-free 1-844-512-2921 within the United States or 1-412-317-6671 when calling internationally (toll). Please use the replay access ID number: 11153994.

About Vistagen

Vistagen (Nasdaq: VTGN) is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other CNS disorders. Vistagen is advancing therapeutics with the potential to be faster-acting, and with fewer side effects and safety concerns, than those currently available for the treatment of anxiety, depression, and multiple CNS disorders. Vistagen's pipeline includes six clinical-stage product candidates, including fasedienol (PH94B), itruvone (PH10), PH80, PH15, and PH284, each an investigational agent belonging to a new class of drugs known as pherines, as well as AV-101, which is an oral prodrug of an antagonist of the N-methyl-D-aspartate receptor (NMDAR). Pherines are neuroactive nasal sprays designed with an innovative proposed mechanism of action that activates chemosensory neurons in the nasal cavity and can beneficially impact key neural circuits in the brain without systemic absorption or direct activity on neurons in the brain. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety, depression, and several other CNS disorders. Connect at www.Vistagen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231106711502/en/

Investors

Mark A. McPartland

Senior Vice President, Investor Relations

(650) 577-3606

markmcp@vistagen.com

Media

Nate Hitchings

SKDK

nhitchings@skdknick.com

Source: Vistagen

FAQ

When will Vistagen host the conference call and webcast?

Vistagen will host the conference call and webcast on Thursday, November 9, 2023.

What is the purpose of the conference call and webcast?

The purpose is to provide a corporate update and report results for Vistagen's fiscal year 2024 second quarter.

What time will the event start?

The event will start at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).

How can participants access the webcast?

Participants can access the webcast through the provided link.

Will there be a telephone playback available?

Yes, a telephone playback of the call will be available after approximately 5:00 p.m. Pacific Time (8:00 p.m. Eastern Time) on November 9, 2023.

What are the dial-in numbers for the conference call?

The US toll-free dial-in number is 1-800-245-3047, and the international dial-in number is 1-203-518-9765. The conference ID is 11153994.

What is the replay access ID number for the telephone playback?

The replay access ID number is 11153994.

Where can I find the webcast link?

The webcast link is: https://viavid.webcasts.com/starthere.jsp?ei=1641124&tp_key=2213157260